CECOG experts' recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cancer

Hilbe W., Abacioglu U., Aebersold D. M., Bachouchi M., Brodowicz T., Gaafar R., ...More

Memo - Magazine of European Medical Oncology, vol.6, no.2, pp.75-82, 2013 (Peer-Reviewed Journal) identifier identifier

  • Publication Type: Article / Article
  • Volume: 6 Issue: 2
  • Publication Date: 2013
  • Doi Number: 10.1007/s12254-013-0088-6
  • Journal Name: Memo - Magazine of European Medical Oncology
  • Page Numbers: pp.75-82
  • Keywords: Bone metastases, Lung cancer, Skeletal-related events, Denosumab, RANK ligand, ZOLEDRONIC ACID, DOUBLE-BLIND, PHASE-III, SOLID TUMORS, RISK-FACTORS, RANK LIGAND, SURVIVAL, RADIOTHERAPY, FRACTURES, PLACEBO
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No